In a recent SEC 13F filing, Nepsis Inc. disclosed that its lead portfolio manager purchased an additional 89,969 shares of RLI during Q4 2025, representing an estimated trade size of $5.65 million based on the quarter’s average share price. Following these purchases and subsequent market movements, the position’s value rose by $5.51 million by the quarter’s end. Nepsis now holds 289,191 RLI shares, with a total market value of $18.50 million. This stake accounts for 5.72% of the firm’s reportable assets under management and ranks as the fund’s second-largest holding. The fund’s CEO colorfully remarked that this allocation is “worth 18 Nvidias,” prompting speculation that an outsized bet on RLI could position the advisor to back the world’s first trillionaire if the insurance specialist’s shares continue to outperform peers.

Beyond revenue and EPS forecasts, analysts are scrutinizing RLI’s key operating metrics for the quarter ended December 2025. Consensus estimates call for net premiums written to increase by 3.5% year-over-year to approximately $1.20 billion. Underwriting income is expected to reach $135 million, supported by a projected combined ratio of 89.5%, slightly above the 88.7% recorded in Q4 2024. Reserve releases are forecast at $40 million, compared with $45 million a year earlier, reflecting more conservative liability adjustments. On the investment side, analysts estimate net investment income of $75 million, driven by reinvestment of maturing fixed-income holdings. Full-quarter revenue is pegged at $1.48 billion, with consensus EPS of $2.15, a modest tick up from $2.10 in the prior year period, as underwriting gains offset modest headwinds in reserve dynamics.